Obstacles in conducting clinical trials in the Saudi Arabia
Background: Conducting clinical research in accordance with the standards of regulatory authorities and within the guidelines of the good clinical practice (GCP) is a matter of concern. It has been noticed that some increment in the conduction of clinical trials outside USA and European countries in the last two decades. The main objective of this study is to identify the magnitude of some obstacles that affect the conduction of clinical trials in accordance with the GCP.
Methods: Developing questionnaire in accordance with the criteria of the GCP would make assessment on how to buildup infrastructure including policy and procedures of the research institution. Recommendation of the study is to perform this questionnaire every other year to assess the progress and development of the research institution.
Conclusions: To identify good clinical researchers, what sort of obstacle(s) regarding conducting clinical trials, and from these obstacles how to resolve it and build up infrastructure for the research institution and also to establish the strategic plan for the research institution.
ICH Topic E 6 R1. Guideline for good clinical practice. Step 5, consolidated guideline from 01.05.1996. Note for guidance on good clinical practice (CPMP/ICH/135/95). January 1997. Available at: www.ema.europa.eu/pdfs/human/ich/013595en.pdf. Accessed on 11 March 2010.
Chow SC, Corey R. Benefits, challenges and obstacles of adaptive clinical trial designs. Orphanet J Rare Dis. 2011;6(1):1.
Alsayeqh AF. Possible Factors For Food Safety Infraction And Fraud Continuity In Restaurants In Saudi Arabia. Available at: SFDA’s website at http://www.sfda.gov.sa. Accessed on 11 March 2010.
Ayalew K. FDA perspective on international clinical trials. US Food and Drug Administration, 2015. Available at: https://www.fda.gov/downloads/drugs/newsevents/ucm441250.pdf. Accessed on 11 March 2017.
Viergever RF, Li K. Trends in global clinical trial registration: an analysis of numbers of registered clinical trials in different parts of the world from 2004 to 2013. BMJ. 2015;5(9):e008932.
McCurry J. Japan unveils 5-year plan to boost clinical research. Lancet. 2007;369(9570):1333-6.
Ito-Ihara T, Hong JH, Kim OJ, Sumi E, Kim SY, Tanaka S, et al. An international survey of physicians regarding clinical trials: a comparison between Kyoto University Hospital and Seoul National University Hospital. BMC Med Res Methodol. 2013;13(1):1.
Jamjoom AB, Ammer M. Jamjoom AM, Samman AM, Gahtani AY. Fate of registered clinical trials performed in Saudi Arabia. Saudi Med J. 2015;36(10):1245–8.
English RA, Lebovitz Y, Giffin RB. Transforming Clinical Research in the United States: Challenges and Opportunities: Workshop Summary. 2010, National Academy of Sciences.
Campbell EG, Weissman JS, Moy E, Blumenthal D. Status of Clinical Research in Academic Health Centers. JAMA. 2001;286(7):800-6.
Hörig H, Marincola E, Marincola FM. Obstacles and opportunities in translational research. Nature Med. 2005;11:705-8.
(12) Goldstein JL, Brown MS. The clinical investigator: bewitched, bothered, and bewildered--but still beloved. J Clin Investigation. 1997;99(12):2803.
Chow SC, Chiu ST. A Note on Design and Analysis of Clinical Trials. Drug Des. 2013;2:102.
Teo AR. The development of clinical research training: past history and current trends in the United States. Academic Medicine. 2009;84(4):433-8.
Thoma A, Farrokhyar F, McKnight L, Bhandari M. How to optimize patient recruitment. Canadian J Surg. 2010;53(3):205.
Kelch RP. Maintaining the public trust in clinical research. New England J Med. 2002;346(4):285.
Alsanea N, Al-Ghammas A, Pangan-Menor J, Tejano RV, Al-Bassam N, Duero-Ebora J, et al. The obstacles facing scientific and medical publishing in Saudi Arabia. Annals of Saudi Med. 2014;34(3):202.
Van Weijen D. How to overcome common obstacles to publishing in English. Res Trends. 2013;35:17-8.